Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy

2018

Background In Italy, there is scarce evidence on the epidemiological and economic burden induced by primary antibody deficiencies.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

31

References

2

Citations